These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 28580493)

  • 1. Cytokine Production in Mixed Cultures of Mesenchymal Stromal Cells from Wharton's Jelly and Peripheral Blood Lymphocytes.
    Poltavtsev AM; Poltavtseva RA; Yushina MN; Volgina NE; Svirshchevskaya EV
    Bull Exp Biol Med; 2017 May; 163(1):169-175. PubMed ID: 28580493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proliferation of Peripheral Blood Lymphocytes and Mesenchymal Stromal Cells Derived from Wharton's Jelly in Mixed and Membrane-Separated Cultures.
    Poltavtsev AM; Poltavtseva RA; Yushina MN; Pavlovich SV; Svirshchevskaya EV
    Bull Exp Biol Med; 2017 Aug; 163(4):542-549. PubMed ID: 28853086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of NK Cells in Mixed Cultures of Wharton's Jelly Mesenchymal Stromal Cells and Peripheral Blood Lymphocytes.
    Svirshchevskaya EV; Poltavtsev AM; Os'mak GZ; Poltavtseva RA
    Bull Exp Biol Med; 2018 Jan; 164(3):339-343. PubMed ID: 29313232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative Analyses of Immunosuppressive Characteristics of Bone-Marrow, Wharton's Jelly, and Adipose Tissue-Derived Human Mesenchymal Stem Cells.
    Karaöz E; Çetinalp Demircan P; Erman G; Güngörürler E; Eker Sarıboyacı A
    Turk J Haematol; 2017 Aug; 34(3):213-225. PubMed ID: 27610554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation and characterization of canine Wharton's jelly-derived mesenchymal stem cells.
    Seo MS; Park SB; Kang KS
    Cell Transplant; 2012; 21(7):1493-502. PubMed ID: 22732242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A xeno-free culture method that enhances Wharton's jelly mesenchymal stromal cell culture efficiency over traditional animal serum-supplemented cultures.
    Julavijitphong S; Wichitwiengrat S; Tirawanchai N; Ruangvutilert P; Vantanasiri C; Phermthai T
    Cytotherapy; 2014 May; 16(5):683-91. PubMed ID: 24119645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Undifferentiated Wharton's Jelly Mesenchymal Stem Cell Transplantation Induces Insulin-Producing Cell Differentiation and Suppression of T-Cell-Mediated Autoimmunity in Nonobese Diabetic Mice.
    Tsai PJ; Wang HS; Lin GJ; Chou SC; Chu TH; Chuan WT; Lu YJ; Weng ZC; Su CH; Hsieh PS; Sytwu HK; Lin CH; Chen TH; Shyu JF
    Cell Transplant; 2015; 24(8):1555-70. PubMed ID: 25198179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cord blood CD34+ cells expanded on Wharton's jelly multipotent mesenchymal stromal cells improve the hematopoietic engraftment in NOD/SCID mice.
    Milazzo L; Vulcano F; Barca A; Macioce G; Paldino E; Rossi S; Ciccarelli C; Hassan HJ; Giampaolo A
    Eur J Haematol; 2014 Nov; 93(5):384-91. PubMed ID: 24797266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization and functionality of the CD200-CD200R system during mesenchymal stromal cell interactions with T-lymphocytes.
    Najar M; Raicevic G; Jebbawi F; De Bruyn C; Meuleman N; Bron D; Toungouz M; Lagneaux L
    Immunol Lett; 2012 Aug; 146(1-2):50-6. PubMed ID: 22575528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human Wharton's Jelly-Derived Stem Cells Display Immunomodulatory Properties and Transiently Improve Rat Experimental Autoimmune Encephalomyelitis.
    Donders R; Vanheusden M; Bogie JF; Ravanidis S; Thewissen K; Stinissen P; Gyselaers W; Hendriks JJ; Hellings N
    Cell Transplant; 2015; 24(10):2077-98. PubMed ID: 25310756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment With Human Wharton's Jelly-Derived Mesenchymal Stem Cells Attenuates Sepsis-Induced Kidney Injury, Liver Injury, and Endothelial Dysfunction.
    Cóndor JM; Rodrigues CE; Sousa Moreira Rd; Canale D; Volpini RA; Shimizu MH; Camara NO; Noronha Ide L; Andrade L
    Stem Cells Transl Med; 2016 Aug; 5(8):1048-57. PubMed ID: 27280799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human umbilical cord Wharton's jelly stem cells and its conditioned medium support hematopoietic stem cell expansion ex vivo.
    Fong CY; Gauthaman K; Cheyyatraivendran S; Lin HD; Biswas A; Bongso A
    J Cell Biochem; 2012 Feb; 113(2):658-68. PubMed ID: 21976004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generating CK19-positive cells with hair-like structures from Wharton's jelly mesenchymal stromal cells.
    Aljitawi OS; Xiao Y; Zhang D; Stehno-Bittel L; Garimella R; Hopkins RA; Detamore MS
    Stem Cells Dev; 2013 Jan; 22(1):18-26. PubMed ID: 22970796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Vitro Generation of IL-35-expressing Human Wharton's Jelly-derived Mesenchymal Stem Cells Using Lentiviral Vector.
    Amari A; Ebtekar M; Moazzeni SM; Soleimani M; Mohammadi Amirabad L; Tahoori MT; Massumi M
    Iran J Allergy Asthma Immunol; 2015 Aug; 14(4):416-26. PubMed ID: 26547710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application potential of mesenchymal stem cells derived from Wharton's jelly in liver tissue engineering.
    Zhang L; Zhao YH; Guan Z; Ye JS; de Isla N; Stoltz JF
    Biomed Mater Eng; 2015; 25(1 Suppl):137-43. PubMed ID: 25538064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential mechanisms underlying ectodermal differentiation of Wharton's jelly mesenchymal stem cells.
    Jadalannagari S; Berry AM; Hopkins RA; Bhavsar D; Aljitawi OS
    Biochem Biophys Res Commun; 2016 Sep; 478(2):831-7. PubMed ID: 27501759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of endothelial progenitor cells obtained from human Wharton's jelly using different culture conditions.
    Zayed SA; Gaafar TM; Samy RM; Sabry D; Nasr AS; Maksoud FA
    Biotech Histochem; 2016 Nov; 91(8):532-539. PubMed ID: 27849398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human Wharton's jelly mesenchymal stem cell secretome display antiproliferative effect on leukemia cell line and produce additive cytotoxic effect in combination with doxorubicin.
    Hendijani F; Javanmard SH; Sadeghi-aliabadi H
    Tissue Cell; 2015 Jun; 47(3):229-34. PubMed ID: 25779671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human Wharton's jelly-derived mesenchymal stromal cells engineered to secrete Epstein-Barr virus interleukin-10 show enhanced immunosuppressive properties.
    Quaranta P; Focosi D; Di Iesu M; Cursi C; Zucca A; Curcio M; Lapi S; Boldrini L; Stampacchia G; Paolicchi A; Scatena F; Freer G; Pistello M
    Cytotherapy; 2016 Feb; 18(2):205-18. PubMed ID: 26794713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunosuppressive properties of mesenchymal stromal cells derived from amnion, placenta, Wharton's jelly and umbilical cord.
    Manochantr S; U-pratya Y; Kheolamai P; Rojphisan S; Chayosumrit M; Tantrawatpan C; Supokawej A; Issaragrisil S
    Intern Med J; 2013 Apr; 43(4):430-9. PubMed ID: 23176558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.